Navigation Links
Strativa Pharmaceuticals Acquires Commercialization Rights to Thin Film Formulation of Ondansetron From MonoSol Rx
Date:6/17/2008

with MonoSol Rx and expand our pipeline of supportive care products." Mr. MacPhee continued, "With two unique, yet complementary delivery systems of ondansetron in our portfolio, Zensana(TM) oral spray and the oral thin film, we are able to offer patients a better opportunity to find a product that meets their individual needs."

A. Mark Schobel, president and CEO of MonoSol Rx, stated, "Strativa is uniquely positioned to market and sell our ondansetron thin film product and we are very excited about the collaboration," Mr. Schobel continued, "Following approval, ondansetron would be one of the first prescription drugs to come to market utilizing thin film drug delivery technology."

About Strativa

Strativa Pharmaceuticals is the proprietary products division of Par Pharmaceutical, Inc. Supported by Par's financial and organizational capabilities including substantial cash resources, Strativa Pharmaceuticals is committed to developing and marketing novel prescription drugs. Its initial focus is on supportive care therapeutics in HIV and oncology. Drawing on the specialty products expertise of its staff, Strativa possesses the resources to prepare products for introduction and to help ensure their success after launch. For additional information, please visit http://www.strativapharma.com.

About Par Pharmaceutical

Par Pharmaceutical, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. For press release and other company information, visit http://www.parpharm.com.

About MonoSol Rx

MonoSol Rx is a drug delivery company specializing in proprietary, dissolving thin film pharmaceutical products. The Company's thin film technology, which is similar in size, shape and thickness to a postage stamp, dissolves rapidly and utilizes a novel process and proprieta
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. MonoSol Rx Licenses Thin Film Formulation of Ondansetron to Strativa Pharmaceuticals, a Division of Par Pharmaceutical
2. Verus Pharmaceuticals Announces Divestiture of Pediatric GI Development Program to Meritage Pharma
3. Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals
4. Alseres Pharmaceuticals, Inc.s Chairman, Peter Savas, Reviews Companys Progress in its Annual Letter to Stockholders
5. Jazz Pharmaceuticals Announces Development Timeline Updates
6. GlaxoSmithKline Acquires Sirtris Pharmaceuticals, Inc., a World Leader in Sirtuin Research and Development
7. Renhuang Pharmaceuticals, Inc. Holds Trade Show for Tianma Pills; Signs Letters of Intent
8. Indevus Pharmaceuticals Provides Update on NEBIDO(R) NDA Status
9. MAP Pharmaceuticals to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
10. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York
11. Antipodean Pharmaceuticals Announces FDA Acceptance of IND for MitoQ(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... AZ (PRWEB) January 22, 2015 Padre Murphy's ... long supporter of Pro Player Health Alliance (PPHA). ... Padre Murphy's in getting everyone, including NFL greats, treated for ... of the leading groups supporting the cause in the valley. ...
(Date:1/22/2015)... 2015 The Incredible Bulk is a revolutionary ... increase lean muscle by up to 30lbs in less than ... of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. , “Our ... step-by-step, scientific diet formula that allows the body to pack ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) wants ... “Live Fearless.” , The “Faces of Fearless” campaign ... how they or someone they know has faced a challenge, ... moment. By telling these types of stories through livefearlessmn.com, participants ...
(Date:1/22/2015)... New York (PRWEB) January 22, 2015 The ... ) in the U.S. District Court, Southern District of West ... Bard, Inc. in that proceeding’s first bellwether trial. In an ... for a new trial after finding that C.R. Bard had ...
(Date:1/22/2015)... A new white paper by The Beryl Institute ... long-term care environment as well as provides recommendations for ... “The Power of Person-Centeredness in Long-Term Care: A View ... patient, resident and family experience in long-term care and ...
Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3
... to get fit are urged to pursue their chosen ... leads to arthritis in later life.// People who severely ... and 30s are at greater risk of developing osteoarthritis, ... Arthritis Research Campaign says that sports injuries can lead ...
... According to French researchers there is no obvious medical ... some patients during cardiac arrest. The near death experience ... recent years.// It involves a feeling of disconnection from ... a cardiac arrest - and often progress down a ...
... low-frequency magnetism reduces the number of seizures suffered by severe ... used a coil which was placed on the side of ... ,The use of high-frequency pulses has been blamed ... first work using low-frequency magnetism.The ten patients in the Gottingen ...
... is no significant difference between three commonly prescribed drugs ... now very widely used in the treatment of depression.// ... that plays an important role in mood. But there ... one another. However, a new study by researchers at ...
... to combat the potentially deadly E. coli 0157 bacteria - ... found that adding small amounts of the spice to samples ... almost all the bacteria. ,Just one teaspoon of ... room temperature. When the same amount of cinnamon was combined ...
... regularly take aspirin because it thins the blood and ... to a widely used class of pain relievers known ... arthritis and other aches and pains. The popular pain ... to a study that sounds a warning for people ...
Cached Medicine News:
(Date:1/23/2015)... , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( ... of directors of Advaxis, Inc. ("Advaxis" or the "Company") ... has breached its fiduciary duties to shareholders. ... an investing website reporting that Advaxis had misrepresented the ...
(Date:1/23/2015)...  HyGreen, Inc., a leader in hand hygiene monitoring, today ... a subsidiary of Ascendis Health Limited, in ... hundreds of millions of patients around the world are ... from patient to patient via the unwashed hands of ...
(Date:1/23/2015)... 2015  iMD Companies, Inc. (ICBU) has repositioned itself as a ... grab a foothold in the hydroponic, hemp and medical marijuana ... presence in the sector, and recently partnering with the Chippewa ... and medical marijuana, iMD is committing to bring its vision ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2HyGreen Partners with RCA Medical in Johannesburg, South Africa 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
... is pleased to announce that its InsightCS® Revenue Cycle ... Behavioral HealthCare (UBHC) with more than 800 users at ... UBHC, a division of the University of Medicine ... InsightCS® system,s complete, end-to-end Patient Access (Registration, Scheduling, ADT) ...
...   Curemark LLC , a Rye, New York-based drug ... III double blind randomized placebo controlled multicenter clinical trial ... endpoints.  The trial compared CM-AT to placebo in children ... demonstrate a statistically significant effect of CM-AT over placebo ...
Cached Medicine Technology:University Behavioral HealthCare Goes Live with Stockell Healthcare Systems' InsightCS® Revenue Cycle Information Management System 2Curemark LLC Reports Positive Phase III Results of CM-AT in Children With Autism 2Curemark LLC Reports Positive Phase III Results of CM-AT in Children With Autism 3
... with the skin to ... field. In addition to ... effect, HIBICLENS' non-drying, low ... compliance with the frequent ...
Aplicare's disposable 1-ounce pouches are designed for individual application and are ideal for reducing waste. They are used in nursing homes, home healthcare settings, blood banks, laboratories, em...
Aplicare's disposable 1-ounce pouches are designed for individual application and are ideal for reducing waste. They are used in nursing homes, home healthcare settings, blood banks, laboratories, em...
... multi-purpose topical gel contains 10% Povidone Iodine ... action. As a pre-operative prep, Povidone Iodine ... prepping solutions under the patient, thus reducing ... is also approved as a one step ...
Medicine Products: